{
  "id": 16105019,
  "title": "International study helps support FDA approval of HIV drug for newborns",
  "url": "https://urgent.news/2026/10/22/international-study-helps-support-fda-approval-of-hiv-drug-for",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-22T20:40:16.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-10-international-fda-hiv-drug-newborns.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "An international study conducted through the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network, including researchers at the University of California San Diego, helped inform the U.S. Food and Drug Administration's (FDA) recent approval of dolutegravir, a second-generation integrase inhibitor, for the treatment of human immunodeficiency virus (HIV-1) in newborns…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}